Podcasts about university college london hospitals

In this piece we discuss risk in medicine with Kevin Fong, a consultant anaesthetist, retrieval medicine specialist, and broadcaster. In a wide-ranging conversation we talk about risk in anaesthesia, the effect of adverse events on individual practitioners and teams, and workforce issues in health. Presented by Andy Cumpstey and Kate Leslie on location at the Annual Scientific Meeting of the Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine in Cairns, Australia, with Professor Kevin Fong, Consultant Anaesthetist and Anaesthetic Lead for Major Incident Preparedness, University College London Hospitals, and Professor of Engagement and Innovation for Science and Medicine at University College London.

Send us a textWelcome to the fifth episode of season five, in conversation with Professor Pranav Pandya. Professor Pandya's Bio:Professor Pranav P PandyaBSc MBBS MD FRCOGConsultant in Fetal MedicinePranav Pandya is a Professor in Fetal Medicine at University College London. He is currently the Director and Clinical Lead of Fetal Medicine services at University College London Hospitals.Pranav is dedicated to caring for pregnant women and in particular the well-being of their baby. His expertise is in the ultrasound examination of the mother and unborn baby(s) with particular interest in first trimester anomalies, fetal cardiology, surgical anomalies and fetal therapy.Pranav is also the Chair of the Fetal Anomaly Screening Programme Advisory Group at the UK National Screening Committee, where he is involved in developing and implementing national policy on fetal anomaly scanning and screening for fetal aneuploidy and implementation of cell free fetal DNA within the NHS.He has published extensively in the field of fetal medicine and is Editor in Chief of a major textbook - Fetal Medicine Basic Science and Clinical Practice.Podcast information:We have not included any patient identifiable information, and this podcast is intended for professional education rather than patient information (although welcome anyone interested in the field to listen). Please get in touch with feedback or suggestions for future guests or topics: conversationsinfetalmed@gmail.com, or via Twitter (X), Bluesky or Instagram via @fetalmedcast.Music by Crowander ('Acoustic romance') used under creative commons licence. Podcast created, hosted and edited by Dr Jane Currie.

Bijna 5 jaar geleden kwam het coronavirus naar Nederland. Komt het nou wel of niet uit een lab? En welke maatregelen waren zinloos en welke zinvol? Was er in aan de talkshowtafel wel ruimte voor het geluid tegen de maatregelen? Te gast zijn prof. dr. Ira Helsloot, hoogleraar Besturen van Veiligheid aan de Radboud Universiteit Nijmegen en voorzitter van de Stichting Crisislab. Ook is aangeschoven, prof. dr. Marcel Levi, internist en tijdens de coronacrisis CEO van de University College London Hospitals. Tevens te gast is drs. Maarten Keulemans, wetenschapsjournalist van de Volkskrant en schreef in de eerste twee jaar van corona 459 artikelen over het virus. Ook werd hij Journalist van het Jaar in 2021 vanwege zijn 'onvermoeibare verslaggeving' over de coronapandemie.

In this week's Talking Tech feature, Poppy discusses how surgeons in the UK are implanting a new electronic chip to help patients with sleep apnoea, a condition affecting 8 million people that causes repeated breathing interruptions during sleep. The chip is placed on a nerve controlling tongue muscles, helping keep airways open. One of the first NHS procedures happened at University College London Hospitals, performed on Natalie Boller, who has suffered from the condition for 10 years.

Thames Water bills will rise by more than a third to an average of £588 over the next five years despite its dismal record on pollution and leaks.Water regulator Ofwat said the UK's biggest water company, which supplies London and was recently fined £18 million for breaking share dividends rules, will be allowed to hike its bills by an inflation-busting £152, or 35 per cent - that's an average £31 a year.The charges are being hiked to fund a £104 billion spending plan, with other water companies in England and Wales following suit increasing customer bills.The Standard podcast is joined by Matthew Topham, lead campaigner at We Own It, a pressure group for public ownership.In part two, patients with sleep apnoea are receiving a choice of two nerve stimulators from University College London Hospitals to combat the condition, and it's the first UK healthcare provider to offer both therapies without needing bulky equipment.We're joined by Mr Ryan Chin Taw Cheong, consultant ENT and sleep surgeon at UCLH's Royal National ENT and Eastman Dental Hospitals. Hosted on Acast. See acast.com/privacy for more information.

As Adrienne reflects on 6 years of the Power Hour, we are going to share some of our favourite episodes from the archives on Thursdays.Today we're sharing April 2023's episode all about Ultra-processed food, with guest Dr Chris van Tulleken. Since this episode Chris has been on a mission to get us discussing our diets and making positive healthy changes, and the phrase ultra-processed food has become common parlance!From the episode notes...Adrienne is joined by the wonderful Dr Chris van Tulleken to discuss his new book Ultra-Processed People. In the book Dr Chris discusses how we have entered a new 'age of eating' where most of our calories come from an entirely novel set of substances called Ultra-Processed Food, food which is industrially processed and designed and marketed to be addictive. But do we really know what it's doing to our bodies?Dr Chris van Tulleken is an infectious disease doctor at University College London Hospitals, and a Medical Research Council clinical research fellow at University College London in the Greg Towers lab, where he studies viral evolution and HIV. He has worked with aid organisations around the world over the past 10 years, including Doctors of the World. He also presents a range of programmes for the BBC including the double-Bafta winning Operation Ouch!. He is on Twitter @DoctorChrisVT Hosted on Acast. See acast.com/privacy for more information.

Listen now as we speak about space exploration, a media career which extends to both television, radio and podcasting. We get into AI, medical safety, the oft made comparison with aviation and the ultimate role of humans and machines in complex systems. This piece was recorded and sent to you directly from The 18th WFSA World Congress of Anaesthesiologists in Singapore. Here we have Desiree Chappell and Monty Mythen speaking with Kevin Fong, OBE MRCP FRCA, a well known British doctor and broadcaster; a consultant anaesthetist and anaesthetic lead for Major Incident Planning at University College London Hospitals and a professor (also at UCL) where he organises and runs an undergraduate course Extreme Environment Physiology. As mentioned here is a link to the excellent new BBC radio series: https://www.bbc.co.uk/programmes/m001wjf8 You can find our guest's insightful Twitter feed here: Dr Kevin Fong (@kevin_fong) / X (twitter.com)

A marked improvement in the outlook for patients with locally advanced cervical cancer has been achieved thanks to a neoadjuvant regimen using standard anti-cancer drugs added to usual therapy. At the ESMO Congress 2023 held in Madrid, Spain, Mary McCormack, PhD, MBBS, FRCR, Consultant Clinical Oncologist at University College London Hospitals, reported findings from the GCIG INTERLACE randomized Phase III trial of induction chemotherapy. This involved the use of carboplatin with paclitaxel for 6 weeks immediately before standard chemoradiotherapy. After the conference, OncTimesTalk’s correspondent Peter Goodwin visited McCormack to find out more about the clinical implications arising from the INTERLACE study.

Adrienne is joined by the wonderful Dr Chris van Tulleken to discuss his new book Ultra-Processed People. In the book Dr Chris discusses how we have entered a new 'age of eating' where most of our calories come from an entirely novel set of substances called Ultra-Processed Food, food which is industrially processed and designed and marketed to be addictive. But do we really know what it's doing to our bodies?Dr Chris van Tulleken is an infectious disease doctor at University College London Hospitals, and a Medical Research Council clinical research fellow at University College London in the Greg Towers lab, where he studies viral evolution and HIV. He has worked with aid organisations around the world over the past 10 years, including Doctors of the World. He also presents a range of programmes for the BBC including the double-Bafta winning Operation Ouch!. He is on Twitter @DoctorChrisVT Hosted on Acast. See acast.com/privacy for more information.

Dr. Amy Ross Russell(1) is joined by a selection of the authors of "Toxic neuropathies; a practical approach", a review recently published in Practical Neurology. The guests, Dr. Duncan Smyth(2), Dr. Aisling Carr(3) and Prof. Michael Lunn(3), explain the background to these conditions and describe approaches to treatment and care of toxic neuropathy patients. Read this latest Editor's Choice paper on the Practical Neurology website (https://pn.bmj.com/content/23/2/120) and the April print issue of the journal. The paper is also discussed by Practical Neurology editors, Dr. Phil Smith and Dr. Geraint Fuller, in their latest podcast: https://soundcloud.com/bmjpodcasts/editors-highlights-of-the-april-2023-issue?in=bmjpodcasts/sets/pn-podcast (1) Neurology, University Hospital Southampton NHS Foundation Trust, UK (2) Dept. of Neurology, Wellington Hospital, Wellington, NZ (3) MRC Centre for Neuromuscular Diseases, National Hospital for Neurology, University College London Hospitals, UK Please subscribe to the Practical Neurology podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Practical Neurology Podcast iTunes page (https://podcasts.apple.com/gb/podcast/pn-podcast/id942932053). The PN podcast is produced by Letícia Amorim and edited by Brian O'Toole. Thank you for listening.

Recently Dr. Charlie Porter published a landmark article in JACC Cardio-Oncology titled "Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology" You can read the article here Our hosts Dr. Stephen Caselli and co-host Dr. Arjun K Ghosh are interviewing Dr. Charlers Porter to discuss the following topic “Permissive Cardiotoxicity”. Dr. Caselli is the executive director of ICOS, and Dr. Ghosh is a consultant cardiologist at University College London Hospitals and Barts Heart Centre. Dr. Porter is the founding Medical Director of cardio-oncology at the University of Kansas Medical Center. Dr. Porter has been actively involved in heart failure and cardiac transplantation for over thirty years in Kansas City. He worked with Dr. William Reed to help launch the third heart transplant program in Missouri and the first in Kansas City in 1985. He was a co-author of the research paper that introduced and validated the Kansas City Cardiomyopathy Questionnaire which has subsequently become one of the leading patient-centered quality-of-life surveys in the world. He had a recent review article published at JACC Cardio-oncology with the following title “Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology”.1 Episode Pearls   1. Permissive Cardiotoxicity is a novel term that represents an essential concept in the field of cardio-oncology and among practicing cardio-oncology specialists. It emphasizes a proactive rather than reactive approach to the continuation of lifesaving cancer therapies to achieve the best oncologic outcome while mitigating associated and potential cardiotoxicities. 2. Permissive cardiotoxicity–based treatment strategies often start with the recognition of this urgent need to commence anticancer therapy and for cardiology evaluation of CV risk factors without delaying important cancer treatment. Such patients may require a cardioprotective strategy implemented without the luxury of a few weeks of escalating GDMT for patients with HFrEF or the scheduling of several diagnostic studies over a period of days or weeks before the patient is deemed ready for cancer therapy. 3. A common example eluding how permissive cardiotoxicity as a concept is important, is trastuzumab interruption (about 62% in the study by Sardesai et. Al) in HER2-positive breast cancer demonstrated worse disease-free (adjusted HR: 4.4) and overall survival (adjusted HR: 4.8) after adjusting for age, stage, grade, estrogen receptor status, node status, and trastuzumab-associated cardiotoxicity.2 4. Another example is that developing severe hypertension as a side effect of VEGF inhibitors is associated with improved cancer outcomes in some tumors sensitive to VEGF inhibitors.3 5. Mindset needs to be changed from treating cardiotoxicity to screening and early detection of cardiotoxicity and from “Should this therapy be discontinued?” to “How can this therapy be continued?” 6. Implementing permissive cardiotoxicity needs collaboration and clinical care needs to be delivered in a multidisciplinary fashion involving the patient, oncologist, pharmacist, and cardio-oncology specialist.   References   1. Porter C, Azam TU, Mohananey D, et al. Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology. JACC CardioOncol. 2022;4(3):302-312. Published 2022 Sep 20. 2. Sardesai S, Sukumar J, Kassem M, et al. Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer. Cardiooncology. 2020;6(1):26. Published 2020 Nov 5. 3. Cai J, Ma H, Huang F, et al. Correlation of bevacizumab-induced hypertension and outcomes of metastatic colorectal cancer patients treated with bevacizumab: a systematic review and meta-analysis. World J Surg Oncol. 2013;11:306. Published 2013 Nov 28. Thank you to our show notes writers for this episode: Abdelrahman Ali, MDCardio-Oncology FellowMD Anderson Cancer Center Department of Cardiology Alana Quadros

I love creating this podcast for many reasons but chief among them is the opportunity it affords me to speak to people with whom I might not necessarily cross paths in my every day. This has never been more true than with Jim Down, a consultant in critical care and anaesthesia at University College London Hospitals who was frontline during the Covid-19 pandemic, attended to former Russian spy Alexander Litvinenko when he was poisoned with Polonium-210 in 2006 and was one of the first on the scene of the Hatfield train disaster.This show is about hearing how my guests have navigated the more challenging parts of life and come out the other side, and Jim's stories and learnings are extraordinary. His openness about his own mental health and the challenges he's had to overcome as a result of the cumulative stress of life in hospital wards, intensive care units and high-stress situations is levelling, to say the least.Jim is also extremely open, warm and thoughtful, and as you'd perhaps expect from someone who has to make life-or-death decisions, shows real compassion. Even as someone who saw the impact of the Covid-19 virus, he makes efforts to understand the people who now say it was a hoax, which feels extraordinarily magnanimous when you hear what he saw, first-hand in 2020.Life in the Balance and Life Support are available to order now.To join the closed Facebook group for the podcast click here >> The Emma Guns Show Forum.To follow me on social media >> Twitter | Instagram.Watch clips from the podcast >> Youtube | The Emma Guns ShowSign up for my newsletter here >> Newsletter. Hosted on Acast. See acast.com/privacy for more information.

A new research paper was published in Oncotarget's Volume 14, entitled, “Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659).” Researchers Leo I. Gordon, Reem Karmali, Jason B. Kaplan, Rakesh Popat, Howard A. Burris III, Silvia Ferrari, Sumit Madan, Manish R. Patel, Giuseppe Gritti, Dima El-Sharkawi, F. Ian Chau, John Radford, Jaime Pérez de Oteyza, Pier Luigi Zinzani, Swaminathan P. Iyer, William Townsend, Harry Miao, Igor Proscurshim, Shining Wang, Shilpi Katyayan, Ying Yuan, Jiaxi Zhu, Kate Stumpo, Yaping Shou, Cecilia Carpio, and Francesc Bosch from Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, University College London Hospitals, Sarah Cannon Research Institute/Tennessee Oncology, Ospedale Papa Giovanni XXIII, University of Texas Health Science Center, Florida Cancer Specialists/Sarah Cannon Research Institute, Royal Marsden Hospital, The Christie NHS Foundation Trust and University of Manchester, Hospital Universitario HM Sanchinarro, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Università di Bologna, Houston Methodist Cancer Center, Takeda Development Center Americas, Inc. (TDCA), Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, University of Texas MD Anderson Cancer Center, and Labcorp Drug Development report an updated analysis from a phase I study of the spleen tyrosine kinase (SYK) and FMS-like tyrosine kinase 3 inhibitor mivavotinib. They present data for the overall cohort of lymphoma patients and the subgroup of patients with diffuse large B-cell lymphoma (DLBCL), including an expanded cohort not included in the initial report. “Mivavotinib (TAK-659/CB-659) is an investigational, oral, reversible, potent dual inhibitor of spleen tyrosine kinase (SYK) and FMS-like tyrosine kinase 3 (FLT3) [18]. SYK is an essential component of the B-cell receptor signaling pathway; abnormal SYK signaling has been implicated in the pathogenesis of DLBCL and several other B-cell malignancies.” Patients with relapsed/refractory lymphoma for which no standard treatment was available received mivavotinib 60–120 mg once daily in 28-day cycles until disease progression/unacceptable toxicity. A total of 124 patients with lymphoma, including 89 with DLBCL, were enrolled. Overall response rates (ORR) in response-evaluable patients were 45% (43/95) and 38% (26/69), respectively. Median duration of response was 28.1 months overall and not reached in DLBCL responders. In subgroups with DLBCL of germinal center B-cell (GCB) and non-GCB origin, ORR was 28% (11/40) and 58% (7/12), respectively. Median progression free survival was 2.0 and 1.6 months in the lymphoma and DLBCL cohorts, respectively. Grade ≥3 treatment-emergent adverse events occurred in 96% of all lymphoma patients, many of which were limited to asymptomatic laboratory abnormalities; the most common were increased amylase (29%), neutropenia (27%), and hypophosphatemia (26%). “These findings support SYK as a potential therapeutic target for the treatment of patients with B-cell lymphomas, including DLBCL.” DOI: https://doi.org/10.18632/oncotarget.28352 Correspondence to: Leo I. Gordon - l-gordon@northwestern.edu About Oncotarget Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form, and then quickly released to Pubmed. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/OncotargetYouTube LinkedIn - https://www.linkedin.com/company/oncotarget

This week, Jonathan is joined by Hugh Selsick, Consultant in Sleep Medicine and Psychiatry at University College London Hospitals, UK. Selsick delves into what led him to his role as a sleep medicine consultant in London all the way from South Africa, as well as unpacking sleep disorders that are often misdiagnosed. Jonathan also discusses Selsick's recent work on the use of cognitive behavioural therapy as a treatment for parasomnias, and the reasons behind the negative effects of the pandemic on sleeping habits. 

How did your intensive care unit manage during COVID19? What are the common experiences of practitioners from the developed world who bravely faced a pandemic like no other? This is part two of a two part piece. The previous installment is here: https://topmedtalk.libsyn.com/intensive-care-during-covid19-p1-topmedtalk The TV show mentioned in this piece is available here: https://www.channel4.com/programmes/help Editor's note; parts of this conversation which suffered from technical issues have been removed from this podcast. Chaired by Ramani Moonesinghe, OBE, Professor of Perioperative Medicine at UCL and a consultant anesthetist at UCL hospitals, Director of the Health Services Research Center of the Royal College of Anaesthetists and national Clinical Director for critical and perioperative care at NHS England with remote assistance from Catherine Motherway, consultant in Anaesthesia and Intensive Care in University Hospital Limerick and contributions from panelists; David Walker, Professor in Anaesthesia and Critical Care Medicine, University College London Hospitals, Honorary Senior Lecturer UCL, Jim Down, Intensivist and Consultant Anaesthetist, University College London Hospital. Colman O'Loughlin, consultant Anaesthesia, Critical Care Medicine, Extracorporeal Life Support at the Mater Hospital, Dublin, Enda O'Connor, physician intensivist and current ICU Lead and Education Lead in St James's Hospital.

How did your intensive care unit manage during COVID19? What are the common experiences of practitioners from the developed world who bravely faced a pandemic like no other? This is part one of a two part piece. The TV show mentioned in this piece is available here: https://www.channel4.com/programmes/help Editor's note; parts of this conversation which suffered from technical issues have been removed from this podcast. Chaired by Ramani Moonesinghe, OBE, Professor of Perioperative Medicine at UCL and a consultant anesthetist at UCL hospitals, Director of the Health Services Research Center of the Royal College of Anaesthetists and national Clinical Director for critical and perioperative care at NHS England, with remote assistance from Catherine Motherway, consultant in Anaesthesia and Intensive Care in University Hospital Limerick and contributions from panelists; David Walker, Professor in Anaesthesia and Critical Care Medicine, University College London Hospitals, Honorary Senior Lecturer UCL, Jim Down, Intensivist and Consultant Anaesthetist, University College London Hospital. Colman O'Loughlin, consultant Anaesthesia, Critical Care Medicine, Extracorporeal Life Support at the Mater Hospital, Dublin, Enda O'Connor, physician intensivist and current ICU Lead and Education Lead in St James's Hospital.

This piece is a worthwhile deep dive into this perioperative medicine and how we go forward with it. Hear the panel speak about what it is they want for the future and what it is they are doing now. With questions submitted from the online audience the panel get into the detail. Essential listening for any student of perioperative medicine. It includes a mention for the Welsh Perioperative Medicine Society, their website is here: https://www.welshpoms.com/ This is part two of a two part piece of the same name. Presented by David Walker, Professor in Anaesthesia and Critical Care Medicine, University College London Hospitals, Honorary Senior Lecturer UCL, Kim Caulfield, Perioperative Medicine Fellow, University College London Hospitals NHS Foundation Trust, Mike Grocott Professor of Anaesthesia and critical care at the University of Southampton, Aislinn Sherwin, a Fellow in Perioperative Medicine and Onco-Anaesthesia at the Peter MacCallum Cancer Centre, Melbourne, Roisin Coary, final year SpR in Geriatric and General Internal Medicine, with a specialist interest in Peri-operative Medicine, Dublin Ireland and Isra Hassan, a post-CCT Perioperative Medicine Fellow at the University College of London Hospital she co-founded the Welsh Perioperative Medicine Society in 2018 which now has over 100 members, and to date has delivered two national conferences, Andrea Haren, perioperative medicine fellow at UCLH she worked with Guys and St Thomas' working with the POPS Clinic she is currently a locum consultant anaesthetist at St. Vincent's Hospital in Dublin and Pádraig Ó Scanaill, Locum Consultant Anaesthetist at the Mater Misericordiae University Hospital, Dublin.

A year and a half in, and in many ways Covid-19 is still an enigma. All over the world, doctors and scientists are still struggling to understand exactly how this new virus undermines our defences and then damages, even destroys, our bodies, in so many different ways. And why are some people completely unaffected? In this edition of The Evidence, Claudia Hammond and her panel of experts chart the remarkable journey to understand this chameleon-like virus, including the long tail of the pandemic, Long Covid. Millions the world over are suffering under the dark shadow of post-Covid, with a multitude of symptoms months after the infection. Some of them, listeners to the programme, share their experiences. And, the background story of the world famous RECOVERY trial, set up at record speed in the UK (but now international) to test which treatments could save the lives of the sickest Covid patients. So far 10 treatments for Covid have been randomised and tested on thousands of patients and the results have shown that six, including the widely used and promoted hydroxychloroquine, make no difference to chances of surviving a hospital stay. While evidence that the cheap, widely-available steroid, dexamethasone, does work, and has so far saved more than a million lives world-wide. Joint chief investigator of RECOVERY, Sir Martin Landray, Professor of Medicine and Epidemiology at the University of Oxford, admits to Claudia that he's been asked to include bee pollen and snake venom in the trial, but so far he's resisted. Claudia's expert panel also includes Professor K. Srinath Reddy, cardiologist and epidemiologist and President of the Public Health Institute of India; Dr Sherry Chou, intensivist and neurologist from the University of Pittsburgh School of Medicine who heads the Global Consortium Study on Neurological Dysfunction in Covid-19 (GCS-NeuroCOVID) and Dr Melissa Heightman, respiratory consultant and Clinical Lead for post-COVID services at University College London Hospitals. Produced by: Fiona Hill, Hannah Fisher and Maria Simons Studio Engineers: Donald MacDonald and Matilda Macari

This piece is a worthwhile deep dive into this perioperative medicine and how we go forward with it. Hear the panel speak about what it is they want for the future and what it is they are doing now. With questions submitted from the online audience the panel get into the detail. Essential listening for any student of perioperative medicine. When should we pre-assess patients? Should all anaesthetists be doing pre-operative sessions? What is it about the role of the anaesthestist that makes it uniquely suited to the discipline of perioperative medicine? This is part one of a two part piece of the same name. Presented by David Walker, Professor in Anaesthesia and Critical Care Medicine, University College London Hospitals, Honorary Senior Lecturer UCL, Kim Caulfield, Perioperative Medicine Fellow, University College London Hospitals NHS Foundation Trust, Mike Grocott Professor of Anaesthesia and critical care at the University of Southampton, Aislinn Sherwin, a Fellow in Perioperative Medicine and Onco-Anaesthesia at the Peter MacCallum Cancer Centre, Melbourne, Roisin Coary, final year SpR in Geriatric and General Internal Medicine, with a specialist interest in Peri-operative Medicine, Dublin Ireland and Isra Hassan, a post-CCT Perioperative Medicine Fellow at the University College of London Hospital she co-founded the Welsh Perioperative Medicine Society in 2018 which now has over 100 members, and to date has delivered two national conferences, Andrea Haren, perioperative medicine fellow at UCLH she worked with Guys and St Thomas' working with the POPS Clinic she is currently a locum consultant anaesthetist at St. Vincent's Hospital in Dublin and Pádraig Ó Scanaill, Locum Consultant Anaesthetist at the Mater Misericordiae University Hospital, Dublin.

"Maybe it's time to evolve our practice" Many believe ultrasound is an essential bedside tool which should be as common as the archetypal Doctor's stethoscope, with training made mandatory for all acute medicine specialists. This piece is structured as a debate where this point of view is advocated and debated. Presented by Mark Edwards, Consultant in Anaesthesia and Perioperative Medicine at The University Hospital Southampton NHS Foundation Trust with Catherine Nix, Consultant Anaesthetist Intensivist at University Hospital Limerick, with panelists; Janette Brohan, Consultant in Anaesthesia and Intensive Care Medicine in Cork University Hospital, David Walker, Professor in Anaesthesia and Critical Care Medicine, University College London Hospitals, Honorary Senior Lecturer UCL, Kevin Murphy, Professor of Endocrinology & Metabolism at University College London, Ashley Miller, Intensivist at Shrewsbury and Telford Hospitals and Monty Mythen, Smiths Medical Professor of Anaesthesia and Critical Care, University College London.

This piece starts with the challenges faced by non-consultant hospital doctors (NCHD's) in this pandemic environment and the challenges of teaching novice anesthesiologists during COVID19. What insights can be gained from this high stress high demand environment where correct and comprehensive training is essential? The conversation is then thrown out to a panel and questions are considered; what is the future of training, what have we learned and what must we prioritize in the near and long term future? Chaired by Janette Brohan, Consultant in Anaesthesia Intensive Care Medicine in Cork University Hospital with an initial short presentation from Niamh McAuliffe Anesthesiologist in Cork University Hospital and featuring the following panellists; Viki Mitchell, consultant anaesthetist and divisional clinical director at University College London Hospitals, Brian O'Brien, Consultant in Anaesthesia and Intensive Care Medicine, at Cork University Hospital, where he is Chairman of Department, Ray O'Conner Consultant in Anaesthesia at Cork University Hospital and Monty Mythen, Smiths Medical Professor of Anaesthesia and Critical Care, University College London.

This piece is a worthwhile deep dive into this perioperative medicine and how we go forward with it. Hear the panel speak about what it is they want for the future and what it is they are doing now. With questions submitted from the online audience the panel get into the detail. Essential listening for any student of perioperative medicine. It includes a mention for the Welsh Perioperative Medicine Society, their website is here: https://www.welshpoms.com/ This is part two of a two part piece of the same name. Presented by David Walker, Professor in Anaesthesia and Critical Care Medicine, University College London Hospitals, Honorary Senior Lecturer UCL, Kim Caulfield, Perioperative Medicine Fellow, University College London Hospitals NHS Foundation Trust, Mike Grocott Professor of Anaesthesia and critical care at the University of Southampton, Aislinn Sherwin, a Fellow in Perioperative Medicine and Onco-Anaesthesia at the Peter MacCallum Cancer Centre, Melbourne, Roisin Coary, final year SpR in Geriatric and General Internal Medicine, with a specialist interest in Peri-operative Medicine, Dublin Ireland and Isra Hassan, a post-CCT Perioperative Medicine Fellow at the University College of London Hospital she co-founded the Welsh Perioperative Medicine Society in 2018 which now has over 100 members, and to date has delivered two national conferences, Andrea Haren, perioperative medicine fellow at UCLH she worked with Guys and St Thomas' working with the POPS Clinic she is currently a locum consultant anaesthetist at St. Vincent's Hospital in Dublin and Pádraig Ó Scanaill, Locum Consultant Anaesthetist at the Mater Misericordiae University Hospital, Dublin.

This piece is a worthwhile deep dive into this perioperative medicine and how we go forward with it. Hear the panel speak about what it is they want for the future and what it is they are doing now. With questions submitted from the online audience the panel get into the detail. Essential listening for any student of perioperative medicine. When should we pre-assess patients? Should all anaesthetists be doing pre-operative sessions? What is it about the role of the anaesthestist that makes it uniquely suited to the discipline of perioperative medicine? This is part one of a two part piece of the same name. Presented by David Walker, Professor in Anaesthesia and Critical Care Medicine, University College London Hospitals, Honorary Senior Lecturer UCL, Kim Caulfield, Perioperative Medicine Fellow, University College London Hospitals NHS Foundation Trust, Mike Grocott Professor of Anaesthesia and critical care at the University of Southampton, Aislinn Sherwin, a Fellow in Perioperative Medicine and Onco-Anaesthesia at the Peter MacCallum Cancer Centre, Melbourne, Roisin Coary, final year SpR in Geriatric and General Internal Medicine, with a specialist interest in Peri-operative Medicine, Dublin Ireland and Isra Hassan, a post-CCT Perioperative Medicine Fellow at the University College of London Hospital she co-founded the Welsh Perioperative Medicine Society in 2018 which now has over 100 members, and to date has delivered two national conferences, Andrea Haren, perioperative medicine fellow at UCLH she worked with Guys and St Thomas' working with the POPS Clinic she is currently a locum consultant anaesthetist at St. Vincent's Hospital in Dublin and Pádraig Ó Scanaill, Locum Consultant Anaesthetist at the Mater Misericordiae University Hospital, Dublin.

In Londen heeft de mutatie van het coronavirus keihard om zich heen geslagen. Ziekenhuizen stroomden vol en konden het nét aan. Omdat deze variant zich ook snel verspreidt in Nederland, worden extra maatregelen aangekondigd, waaronder mogelijk een avondklok. Daarover spreken Roos Abelman en Donatello Piras uitgebreid met Marcel Levi, CEO van University College London Hospitals (UCLH) en daarmee verantwoordelijk voor 9 ziekenhuizen in de Britse hoofdstad. 'De avondklok is een soort bliksemafleider geworden in Nederland. Er wordt over bijna niets anders meer gepraat in de politiek en media. Terwijl er ook andere maatregelen zijn om mensen thuis te houden.'

On the day that hundreds of alleged members of Italy's most powerful mafia group go on trial, Adam is joined by documentary filmmaker, Tobias Jones, to explain how the mobsters may be taking advantage of the pandemic. And we talk to Marcel Levi, Chief Executive of University College London Hospitals, about the mental health of NHS workers at the moment. Studio Director: Emma Crowe Producers: Alix Pickles, Rick Kelsey Assistant Editor: Sam Bonham Editor: Dino Sofos

Een gesprek vanuit London met arts en ziekenhuisdirecteur Marcel Levi, CEO van de University College London Hospitals. Een gesprek over vaccinaties en de nieuwe virusvariant. Er is veel discussie de laatste week over het coronabeleid van het kabinet Rutte. In Buitenhof VVD-coryfee Neelie Kroes. En het eindrapport van de Parlementaire ondervragingscommissie Kinderopvangtoeslag sloeg in als een bom. Grote vraag hoe nu verder? CDA-kamerlid Pieter Omtzigt en SP-collega Renske Leijten nemen het voortouw.

Een gesprek vanuit London met arts en ziekenhuisdirecteur Marcel Levi, CEO van de University College London Hospitals. Een gesprek over vaccinaties en de nieuwe virusvariant. Er is veel discussie de laatste week over het coronabeleid van het kabinet Rutte. In Buitenhof VVD-coryfee Neelie Kroes. En het eindrapport van de Parlementaire ondervragingscommissie Kinderopvangtoeslag sloeg in als een bom. Grote vraag hoe nu verder? CDA-kamerlid Pieter Omtzigt en SP-collega Renske Leijten nemen het voortouw.

PvdA-leider Lodewijk Asscher is te gast. Hoe kom je nog aan een woning, als starter of jong gezin? Een gesprek met arts en ziekenhuisdirecteur Marcel Levi, CEO van de University College London Hospitals; hij had een pittige klus: hij mocht alle zeventien ziekenhuizen in Centraal en Noord-Londen door de eerste coronagolf loodsen, in de toen zwaar getroffen Britse hoofdstad. Wie zijn wij, mensen, homo sapiens, en hoe zijn wij zo geworden? Zijn boeken liggen op vele nachtkastjes, waaronder dat van oud-president Barack Obama. Historicus en Israëlisch topauteur Yuval Noah Harari probeert een antwoord te geven in dit lijvige stripboek Sapiens, een beeldverhaal of graphic novel, een bewerking van zijn gelijknamige boek uit 2014. Presentatie: Pieter Jan Hagens

PvdA-leider Lodewijk Asscher is te gast. Hoe kom je nog aan een woning, als starter of jong gezin? Een gesprek met arts en ziekenhuisdirecteur Marcel Levi, CEO van de University College London Hospitals; hij had een pittige klus: hij mocht alle zeventien ziekenhuizen in Centraal en Noord-Londen door de eerste coronagolf loodsen, in de toen zwaar getroffen Britse hoofdstad. Wie zijn wij, mensen, homo sapiens, en hoe zijn wij zo geworden? Zijn boeken liggen op vele nachtkastjes, waaronder dat van oud-president Barack Obama. Historicus en Israëlisch topauteur Yuval Noah Harari probeert een antwoord te geven in dit lijvige stripboek Sapiens, een beeldverhaal of graphic novel, een bewerking van zijn gelijknamige boek uit 2014. Presentatie: Pieter Jan Hagens

Our expert panel look at why access to data during the pandemic was important and whether Covid-19 has permanently changed the country's relationship with data. Host Andrea Downey is joined by: Caroline Cake, chief executive of Health Data Research UK Cathie Sudlow, director of British Heart Foundation Data Science Centre, and consultant stoke neurologist in Edinburgh Dr Ami Banerjee, associate professor in clinical data science and consultant cardiologist at University College London Hospitals and Barts NHS Trusts

Discussion begins with thoughts about University College London (UCL)'s Masters Course in Perioperative Medicine, moving further to the various ways in which people can learn more about the specialty The wider conversation reaches out into the field of anaesthesia and the constant shortage of practitioners that there is in the UK and more widely around the world. Also, if you're intrigued, here's the link to the free 4 week course discussed in this podcast: https://www.ucl.ac.uk/lifelearning/courses/perioperative-medicine Presented by Desiree Chappell and Monty Mythen with their guests David Walker, Professor in Anaesthesia and Critical Care Medicine, University College London Hospitals, Honorary Senior Lecturer UCL and Dr Rob Stephens, Consultant in Anaesthesia, UCLH, Hon Senior Lecturer in Anaesthesia, UCL.

Discussion begins with thoughts about University College London (UCL)'s Masters Course in Perioperative Medicine, moving further to the various ways in which people can learn more about the specialty The wider conversation reaches out into the field of anaesthesia and the constant shortage of practitioners that there is in the UK and more widely around the world. Also, if you're intrigued, here's the link to the FREE 4 week course discussed in this podcast: https://www.ucl.ac.uk/lifelearning/courses/perioperative-medicine Presented by Desiree Chappell and Monty Mythen with their guests David Walker, Professor in Anaesthesia and Critical Care Medicine, University College London Hospitals, Honorary Senior Lecturer UCL and Dr Rob Stephens, Consultant in Anaesthesia, UCLH, Hon Senior Lecturer in Anaesthesia, UCL.

Evidence from China, Italy, the USA and now the UK shows categorically that people with diabetes can get seriously ill if they're infected with the new coronavirus. Researchers are trying to untangle the risks for Type 1 and Type 2 but so far, diabetes isn't included in the government's high risk patient group. NHS England's National Specialty Advisor, Professor Partha Kar, tells Claudia Hammond that he believes an individual risk calculator which will enable people to work out their own risk, and so shield themselves accordingly, will be the best way forwards. In the meantime, Dr Kar says, glucose control is essential and people should check their ketone levels as soon as they start to feel unwell. BBC Radio Science Unit producer Beth and her husband Andy (who has Type 1 diabetes) describe to Claudia their experience of Andy getting very ill with Covid-19. They discovered ketone levels appeared at much lower blood glucose levels than normal, something that Dr Kar says appears to be a feature of Covid-19 infection. Erika Wright is back at University Hospital Southampton NHS Foundation Trust. Clinical lead and consultant in critical care, Dr Sanjay Gupta, talks about success giving critically ill patients oxygen using non-invasive ventilation: CPAP - continuous positive airway pressure. He also describes reorganising the hospital's critical care into four sections: patients positive for Covid, negative for Covid, those waiting for test results and those who test negative but are symptoms positive. Nationally, he tells Erika, those who falsely test negative, is between 5-10%. And Inside Health contributor Dr Margaret McCartney delves into the accuracy of antigen swab tests (the test that tells you whether you have the virus or not). False negatives, test results that report the person doesn't have the virus when in fact they do, have serious implications for health care professionals, who might return to work on the basis of a mistaken result. Caution is advised, Dr McCartney advises, when symptoms contradict the test result. A cytokine storm is a variant on a hyperactive immune reaction, where the body thinks its own tissues are invaders. Cytokines are small proteins that trigger more immune activity or less. In a cytokine storm the cytokines rage through the bloodstream, throwing our immune system out of balance and leading to severe illness and even death. This hyper inflammation has been seen in Covid-19 patients and Dr Jessica Manson, consultant rheumatologist at University College London Hospitals and co-chair of the national group of hyper inflammation doctors, tells Claudia what is and isn't known about how to treat cytokine storms in patients with coronavirus. Producer: Fiona Hill

Marcel Levi belt om 6 uur ’s ochtends in vanuit Londen. Als CEO van University College London Hospitals coördineert hij aldaar de reorganisatie van meer dan 15 ziekenhuizen. Not an easy job. In dit interview schetst hij de situatie in de Engelse frontlinie, neemt hij het laatste nieuws door rondom de prime minister en heeft hij een positieve boodschap voor de coassistent. Een fris en interessant gesprek in deze bijzondere periode tussen nieuwsgierige artsen in spé en een ervaren arts aan de andere kant van het kanaal. Aflevering 36 van KoffieCo de podcast is nu te beluisteren!

We are joined in this episode by Prof Marcel Levi, the CEO of University College London Hospitals and a practicing Haematology consultant that specialises in coagulopathies, thrombosis and angioedema. This wide ranging discussion initially covers the skill of balancing clinical and managerial work, and how a medical approach to problem solving can be applied to board meetings. We discuss the clotting cascade, and why coagulation is far simpler than medical text books convey, the treatment of DIC and Vitamin K deficiency and how to understand a clotting screen. Finally we move onto Haemophilia, Angioedema and why Haematology is the best speciality to work in.

Streamed live from the 2019 Prehabilitation World Congress and Annual London Peri-Operative Medicine Congress. Presented by Desiree Chappell and Monty Mythen with their guests David Walker, Professor in Anaesthesia and Critical Care Medicine, University College London Hospitals, Honorary Senior Lecturer UCL and Dr Rob Stephens, Consultant in Anaesthesia, UCLH, Hon Senior Lecturer in Anaesthesia, UCL.

The global health burden of heart failure is high, both as the common end-point for many cardiovascular diseases (e.g. hypertension and heart attacks) and a common point on the trajectory of non-cardiovascular diseases (e.g. chronic respiratory disease). Despite advances in treatment, our ability to tailor strategies for prevention or management to individuals with heart failure is currently limited. Large-scale electronic health records and novel data analysis techniques have great potential to improve the status quo in both research and practice. In this talk, Amitava Banerjee examines the real progress and the limitations of recent big data research in heart failure, from epidemiology to machine learning. Amitava Banerjee is Associate Professor in Clinical Data Science at University College London, and Honorary Consultant Cardiologist at University College London Hospitals and Barts Health NHS Trusts. He is a pragmatic researcher, a passionate educator and a practising clinician, with interests spanning data science, cardiovascular disease, global health, training and evidence-based healthcare. After qualifying from Oxford Medical School, he trained as a junior doctor in Oxford, Newcastle, Hull and London. His interest in preventive cardiology and evidence-based medicine led to a Masters in Public Health at Harvard (2004/05), an internship at the World Health Organisation(2005) and DPhil in epidemiology from Oxford (2010). He was Clinical Lecturer in Cardiovascular Medicine at the University of Birmingham, before moving to UCL in 2015. He works across two busy tertiary care settings: University College London Hospitals and Barts Health NHS Trusts with both inpatient and outpatient commitments. Although he is subspecialised in heart failure, he has ongoing practice in acute general cardiology and a keen interest in the diagnosis and management of atrial fibrillation. His clinical work very much informs his research and vice versa, whether in the evaluation of medical technology or the ethics of large-scale use of patient data. This talk was held as part of the Big Data Epidemiology module which is part of the MSc in Evidence-Based Health Care and the MSc in EBHC Medical Statistics.

The global health burden of heart failure is high, both as the common end-point for many cardiovascular diseases (e.g. hypertension and heart attacks) and a common point on the trajectory of non-cardiovascular diseases (e.g. chronic respiratory disease). Despite advances in treatment, our ability to tailor strategies for prevention or management to individuals with heart failure is currently limited. Large-scale electronic health records and novel data analysis techniques have great potential to improve the status quo in both research and practice. In this talk, Amitava Banerjee examines the real progress and the limitations of recent big data research in heart failure, from epidemiology to machine learning. Amitava Banerjee is Associate Professor in Clinical Data Science at University College London, and Honorary Consultant Cardiologist at University College London Hospitals and Barts Health NHS Trusts. He is a pragmatic researcher, a passionate educator and a practising clinician, with interests spanning data science, cardiovascular disease, global health, training and evidence-based healthcare. After qualifying from Oxford Medical School, he trained as a junior doctor in Oxford, Newcastle, Hull and London. His interest in preventive cardiology and evidence-based medicine led to a Masters in Public Health at Harvard (2004/05), an internship at the World Health Organisation(2005) and DPhil in epidemiology from Oxford (2010). He was Clinical Lecturer in Cardiovascular Medicine at the University of Birmingham, before moving to UCL in 2015. He works across two busy tertiary care settings: University College London Hospitals and Barts Health NHS Trusts with both inpatient and outpatient commitments. Although he is subspecialised in heart failure, he has ongoing practice in acute general cardiology and a keen interest in the diagnosis and management of atrial fibrillation. His clinical work very much informs his research and vice versa, whether in the evaluation of medical technology or the ethics of large-scale use of patient data. This talk was held as part of the Big Data Epidemiology module which is part of the MSc in Evidence-Based Health Care and the MSc in EBHC Medical Statistics.

The Lighthouse is a multi-agency service for children and young people in Barnet, Camden, Enfield, Haringey and Islington who have experienced any form of sexual abuse, including exploitation. At The Lighthouse, the child is at the centre, to make sure they have a safe place to recover at their own pace and rebuild their lives. The Lighthouse (Child House) is led by University College London Hospitals in partnership with NSPCC and Tavistock and Portman NHS Trust and will be piloted for two years. In this podcast episode Ali is joined by two members of the Lighthouse team: Emma Harewood, Service Manager and Deborah Hodes, Community Paediatrician and Health Lead, along with Jon Brown, Head of Development and Impact at the NSPCC. Emma, Deborah and Jon provide an insight into how The Lighthouse was established, discussing how the NSPCC along with four core funders (the Home Office, NHS England, the Mayor's Office for Policing and Crime (MOPAC) and the Department for Education) helped shape it to become the first service of its kind in the UK. We hear about the range of services children can access under one roof from therapeutic and medical services to support with police investigations, the court system and counselling for them and their family. They also talk about how children are consulted at every step as well as the future plans for The Lighthouse service. View the podcast transcript on the NSPCC Learning website. 

What can be done about race inequality in the NHS workforce? How can we ensure representative leadership happens? Helen McKenna talks with Yvonne Coghill, Director at NHS England Workforce Race Equality Standard (WRES); Dionne Daniel, Project Lead, Nursing Workforce Remodelling Research Project; and Ben Morrin, Director of Workforce at University College London Hospitals. Related reading Diversity should be a strategic priority Leadership in today's NHS: delivering the impossible Closing the gap on BME representation

How has sedation in endoscopy evolved over the years? What’s the current practice and how it varies within the UK? Dr George Webster, consultant gastroenterologist and hepatologist at the University College London Hospitals, answers these questions in conversation with Frontline Gastroenterology’s Trainee Associate Editor James Maurice (Imperial College London). They also explore the details of a paper recently published by the journal and the training opportunities for young gastroenterologists. Listen until the end for details of the upcoming British Society of Gastroenterology Endoscopy Live 2019, which will be held on the 7th and 8th of March in Gateshead, UK (https://www.bsg.org.uk/events/bsg-endoscopy-live.html). Read the full review paper on the FG website: Deep sedation and anaesthesia in complex gastrointestinal endoscopy: a joint position statement endorsed by the British Society of Gastroenterology (BSG), Joint Advisory Group (JAG) and Royal College of Anaesthetists (RCoA) https://fg.bmj.com/content/early/2019/01/09/flgastro-2018-101145

In this episode, Prof Marcel Levi, Consultant Physician and Chief Executive of University College London Hospitals and Prof Clare Gerada, GP and Past Chairperson of the Royal College of General Practitioners, discuss whistleblowing, changing the culture within the NHS and the role of doctors as managers. Visit [https://www.rsm.ac.uk/resources/podcasts/](https://www.rsm.ac.uk/resources/podcasts/) [](https://videos.rsm.ac.uk/)for more content.

The first podcast brought to you by dementiaresearcher.nihr.ac.uk a new website for early career researchers - everything you need, all in one place. This week’s title is 'Managing a clinical and research career - The life of a clinical academic is a constant balancing act between the demands of delivering patient care and the requirement of driving research relevant to that. Although they are complimentary, there is often a gap between basic science and clinical application to be traversed. In this recording Amy Monaghan talks to Timothy Rittman from University of Cambridge and Addenbrookes Hospital and Ione Woollacott and Akin Nihat from University College London and University College London Hospitals. We hear how these three individuals meet this challenge, and what advice they might have for others. Here are a few useful links referenced in todays recording: www.twitter.com/hashtag/cvoffailures?lang=en https://www.pocket-lint.com/apps/news/136472-what-is-slack-and-how-does-it-work https://www.thirdsector.co.uk/kirsty-marrins-use-slack-internal-communications/digital/article/1404584

NHS hospitals must be willing to dispose of surplus land to help convince the Treasury to invest in new premises that are fit for purpose, the head of a major government review has urged. Robert Naylor, former chief executive of University College London Hospitals, who was asked by the health secretary, Jeremy Hunt, to produce a review of NHS property and estates - and in this interview we asked him how his plans would work, and what would be done with the land sold. Read Gareth Iacobucci's report: http://www.bmj.com/content/357/bmj.j2072

In this podcast, Hanna Murphy (NHS Employers) speaks to Claire London and Jeremy Over from University College London Hospitals about the work they have been doing to embed values in their recruitment (and other HR) policies for different staff groups.